Engineers Gate Manager’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$698K Sell
19,273
-30,541
-61% -$1.04M 0.01% 1294
2026
Q1
$1.65M Sell
49,814
-457
-0.9% -$19.3K 0.02% 802
2025
Q4
$2.33M Sell
50,271
-2,044
-4% -$85.5K 0.03% 635
2025
Q3
$1.83M Sell
52,315
-17,762
-25% -$617K 0.02% 818
2025
Q2
$2.07M Buy
70,077
+43,705
+166% +$1.25M 0.03% 713
2025
Q1
$787K Sell
26,372
-7,360
-22% -$225K 0.01% 1199
2024
Q4
$966K Buy
+33,732
New +$1.12M 0.02% 1029
2024
Q3
Sell
-9,414
Closed -$303K 2159
2024
Q2
$303K Sell
9,414
-5,670
-38% -$197K 0.01% 1460
2024
Q1
$586K Buy
15,084
+2,661
+21% +$93.1K 0.02% 1119
2023
Q4
$382K Buy
12,423
+2,583
+26% +$64.7K 0.01% 1316
2023
Q3
$220K Buy
+9,840
New +$224K 0.01% 1454
2020
Q3
Sell
-12,754
Closed -$223K 1720
2020
Q2
$223K Sell
12,754
-15,070
-54% -$295K 0.01% 1390
2020
Q1
$454K Buy
+27,824
New +$574K 0.03% 819
2019
Q2
Sell
-33,993
Closed -$515K 1175
2019
Q1
$515K Buy
+33,993
New +$544K 0.03% 599
2018
Q2
Sell
-14,217
Closed -$363K 992
2018
Q1
$363K Buy
+14,217
New +$339K 0.02% 651

Other funds holding COLL

Engineers Gate Manager's COLL Position: Q2 2026 in Review

Engineers Gate Manager reduced its Collegium Pharmaceutical (COLL) stake by 61% in Q2 2026, selling an estimated $1.04M and leaving 19,273 shares worth $698K. The position accounts for 0.01% of the portfolio, ranked #1294.

Engineers Gate Manager first reported a position in COLL in Q1 2018 and has held it in 15 quarters since. The position peaked at $2.33M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Engineers Gate Manager held 19,273 shares of Collegium Pharmaceutical worth $698K as of Q2 2026.
  • Engineers Gate Manager sold 30,541 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.04M.
  • Collegium Pharmaceutical made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1294 holding.
  • Engineers Gate Manager first reported a position in Collegium Pharmaceutical in Q1 2018 and has held it in 15 quarters since.
  • Engineers Gate Manager's Collegium Pharmaceutical position peaked at $2.33M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.